Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Grantham, Mayo, Van Otterloo & Co. LLC · Q2 2026 13F · SEC CIK 1352662

Jeremy Grantham portfolio

Hedge fundGMO 13F holdings. Filed 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$44.4B
Reported positions
661
Top holdings a year, 3 yrs
+17.8%
Assets under management
$81.0B

Jeremy Grantham is the co-founder of GMO, which reported 661 positions worth $44.4B in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Microsoft Corp (MSFT, 5.7%), Lam Research Corp (LRCX, 5.3%), Alphabet Inc (GOOGL, 4.9%). A portfolio copying its top holdings returned 17.8% a year over the last 3 years, against 20.4% for the S&P 500.

Jeremy Grantham holdings largest 50 of 661 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Jeremy Grantham 13F holdings
Stock% of 13F valueShare changeReported value
MSFTMicrosoft Corp5.7%+10.4%$2.5B
LRCXLam Research Corp5.3%-20.8%$2.4B
GOOGLAlphabet Inc4.9%-11.1%$2.2B
AAPLApple Inc4.5%-1.3%$2.0B
METAMeta Platforms Inc4.4%+12.2%$1.9B
JNJJohnson & Johnson4.1%-2.3%$1.8B
AMZNAmazon Com Inc3.3%-1.5%$1.5B
TXNTexas Instrs Inc3.1%-7.6%$1.4B
TMOThermo Fisher Scientific Inc3.1%+9.5%$1.4B
AVGOBroadcom Inc2.8%-2.4%$1.2B
KLACKla Corp2.6%+744.3%$1.2B
UNHUnitedhealth Group Inc2.6%-10.6%$1.2B
VVisa Inc2.6%+9.3%$1.1B
NVDANvidia Corporation2.1%—$934.8M
MAMastercard Incorporated2.1%+91.3%$934.1M
USBUS Bancorp2.0%-22.1%$899.1M
LLYEli Lilly & Co2.0%-0.8%$892.3M
MRKMerck & Co Inc2.0%-3.3%$871.9M
ABTAbbott Laboratories1.8%-1.3%$798.0M
NFLXNetflix Inc.1.7%+155.6%$739.0M
CIThe Cigna Group1.6%-0.8%$710.4M
CRMSalesforce Inc1.6%+0.1%$693.7M
KOCoca Cola Co1.5%-0.7%$668.0M
ELVElevance Health Inc Formerly1.5%-12.7%$654.2M
TJXTjx Cos Inc New1.3%-0.9%$557.4M
STZConstellation Brands Inc1.3%-0.7%$556.1M
UBERUber Technologies Inc1.2%+0.2%$533.2M
ACNAccenture PLC Ireland1.1%+2.1%$495.8M
ISRGIntuitive Surgical Inc1.1%-0.2%$488.3M
HLTHilton Worldwide Hldgs Inc1.0%-37.8%$456.4M
SNPSSynopsys Inc1.0%+5.7%$429.0M
DGXQuest Diagnostics Inc0.9%+0.3%$400.2M
ASMLAsml Hldg NV0.7%-1.7%$302.4M
TWTradeweb Mkts Inc0.6%+0.5%$265.4M
TDToronto Dominion Bk Ont0.5%-11.7%$210.4M
GSKGsk PLC0.4%+2.2%$188.7M
DBDeutsche Bk AG0.4%+29.0%$179.1M
RIORio Tinto PLC0.4%-8.3%$174.6M
ARMKAramark0.4%-1.0%$164.6M
TSMTaiwan Semiconductor Manufac0.4%-12.0%$157.4M
PMPhilip Morris Intl Inc0.3%—$140.4M
PGProcter & Gamble Co0.3%+4.8%$137.3M
VODVodafone Group PLC0.3%-0.3%$133.1M
DARDarling Ingredients Inc0.3%-15.0%$125.7M
ALBAlbemarle Corp0.3%-1.1%$121.1M
TTETotalenergies SE0.3%+4.3%$121.0M
BNSBank Nova Scotia B C0.3%+13.9%$120.0M
SQMSociedad Quimica Y Minera de0.3%-4.0%$119.4M
RUNSunrun Inc0.2%+2.4%$107.1M
GEGe Aerospace0.2%-13.0%$104.6M

What Jeremy Grantham bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+22.4% /yr
S&P 500 +20.1%
3 years
+17.8% /yr
S&P 500 +20.4%
5 years
+12.7% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$44.4B661
Q1 2026$39.1B628
Q4 2025$39.1B653
Q3 2025$35.4B597
Q2 2025$33.1B604
Q1 2025$31.7B615
Q4 2024$30.7B570
Q3 2024$31.9B559
Q2 2024$29.6B525
Q1 2024$27.5B513
Q4 2023$22.7B485
Q3 2023$21.2B572

Questions about Jeremy Grantham's portfolio

Who is Jeremy Grantham?

Jeremy Grantham is the co-founder of GMO, a hedge fund that files its US stock holdings with the SEC on Form 13F under the name Grantham, Mayo, Van Otterloo & Co. LLC.

What stocks does Jeremy Grantham own?

Grantham, Mayo, Van Otterloo & Co. LLC's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 661 positions worth $44.4B. The largest are Microsoft Corp (MSFT) at 5.7%, Lam Research Corp (LRCX) at 5.3%, Alphabet Inc (GOOGL) at 4.9%, Apple Inc (AAPL) at 4.5% and Meta Platforms Inc (META) at 4.4%.

What did Jeremy Grantham buy last quarter?

In Q2 2026, Grantham, Mayo, Van Otterloo & Co. LLC added Kla Corp (KLAC) (+744.3% shares), Netflix Inc. (NFLX) (+155.6% shares) and Mastercard Incorporated (MA) (+91.3% shares), compared with its Q1 2026 filing.

What did Jeremy Grantham sell last quarter?

In Q2 2026, Grantham, Mayo, Van Otterloo & Co. LLC cut from its top 50 Solaredge Technologies Inc (SEDG), cut from its top 50 Nexgen Energy Limited (canada) (NXE), Hilton Worldwide Hldgs Inc (HLT) (-37.8% shares), US Bancorp (USB) (-22.1% shares) and Lam Research Corp (LRCX) (-20.8% shares), compared with its Q1 2026 filing.

How has Jeremy Grantham's portfolio performed?

A portfolio copying Grantham, Mayo, Van Otterloo & Co. LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +17.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +22.4% against +20.1%. Over 5 years: +12.7% a year against +11.6%.

When is Grantham, Mayo, Van Otterloo & Co. LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Grantham, Mayo, Van Otterloo & Co. LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Grantham, Mayo, Van Otterloo & Co. LLC manage?

Grantham, Mayo, Van Otterloo & Co. LLC reported $81.0B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $44.4B.